|
1
|
Man TK, Chintagumpala M, Visvanathan J, et
al: Expression profiles of osteosarcoma that can predict response
to chemotherapy. Cancer Res. 65:8142–8150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:32009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer. 75:203–210. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pratap J, Lian JB, Javed A, Barnes GL, Van
Wijnen AJ, Stein JL and Stein GS: Regulatory roles of Runx2 in
metastatic tumor and cancer cell interactions with bone. Cancer
Metastasis Rev. 25:589–600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wan X, Kim SY, Guenther LM, et al: Beta4
integrin promotes osteosarcoma metastasis and interacts with ezrin.
Oncogene. 28:3401–3411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meyers PA, Heller G, Healey JH, Huvos A,
Applewhite A, Sun M and LaQuaglia M: Osteogenic sarcoma with
clinically detectable metastasis at initial presentation. J Clin
Oncol. 11:449–453. 1993.PubMed/NCBI
|
|
7
|
Harris MB, Gieser P, Goorin AM, et al:
Treatment of metastatic osteosarcoma at diagnosis: A Pediatric
Oncology Group Study. J Clin Oncol. 16:3641–3648. 1998.PubMed/NCBI
|
|
8
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wrana JL: Crossing Smads. Science STKE.
2000:re12000.
|
|
10
|
Anderson DM, Maraskovsky E, Billingsley
WL, et al: A homologue of the TNF receptor and its ligand enhance
T-cell growth and dendritic-cell function. Nature. 390:175–179.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wong BR, Rho J, Arron J, et al: TRANCE is
a novel ligand of the tumor necrosis factor receptor family that
activates c-Jun N-terminal kinase in T cells. J Biol Chem.
272:25190–25194. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gould KL, Bretscher A, Esch FS and Hunter
T: cDNA cloning and sequencing of the protein-tyrosine kinase
substrate, ezrin, reveals homology to band 4.1. EMBO J.
8:4133–4233. 1989.PubMed/NCBI
|
|
13
|
Yu Y, Khan J, Khanna C, Helman L, Meltzer
PS and Merlino G: Expression profiling identifies the cytoskeletal
organizer ezrin and the developmental homeoprotein Six-1 as key
metastatic regulators. Nat Med. 10:175–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Modi WS, Dean M, Seuanez HN, Mukaida N,
Matsushima K and O'Brien SJ: Monocyte-derived neutrophil
chemotactic factor (MDNCF/IL-8) resides in a gene cluster along
with several other members of the platelet factor 4 gene
superfamily. Hum Genet. 84:185–187. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andrews EA, Palecek J, Sergeant J, Taylor
E, Lehmann AR and Watts FZ: Nse2, a component of the Smc5-6
complex, is a SUMO ligase required for the response to DNA damage.
Mol Cell Biol. 25:185–196. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Green RE, Krause J, Briggs AW, et al: A
draft sequence of the Neandertal genome. Science. 328:710–722.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pearson G, Robinson F, Beers Gibson T, et
al: Mitogen-activated protein (MAP) kinase pathways: Regulation and
physiological functions. Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Denhardt DT, Noda M, O'Regan AW, Pavlin D
and Berman JS: Osteopontin as a means to cope with environmental
insults: Regulation of inflammation, tissue remodeling, and cell
survival. J Clin Invest. 107:1055–1061. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Standal T, Borset M and Sundan A: Role of
osteopontin in adhesion, migration, cell survival and bone
remodeling. Exp Oncol. 26:179–184. 2004.PubMed/NCBI
|
|
20
|
Kern SE, Kinzler KW, Bruskin A, Jarosz D,
Friedman P, Prives C and Vogelstein B: Identification of p53 as a
sequence-specific DNA-binding protein. Science. 252:1708–1711.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bretscher A, Edwards K and Fehon RG: ERM
proteins and merlin: Integrators at the cell cortex. Nat Rev Mol
Cell Biol. 3:586–599. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Louvet-Vallée S: ERM proteins: From
cellular architecture to cell signaling. Biol Cell. 92:305–316.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khanna C, Khan J, Nguyen P, et al:
Metastasis-associated differences in gene expression in a murine
model of osteosarcoma. Cancer Res. 61:3750–3759. 2001.PubMed/NCBI
|
|
24
|
Khanna C, Wan X, Bose S, et al: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nestl A, Von Stein OD, Zatloukal K, Thies
WG, Herrlich P, Hofmann M and Sleeman JP: Gene expression patterns
associated with the metastatic phenotype in rodent and human
tumors. Cancer Res. 61:1569–1577. 2001.PubMed/NCBI
|
|
26
|
Aplin AE, Howe AK and Juliano R: Cell
adhesion molecules, signal transduction and cell growth. Curr Opin
Cell Biol. 11:737–744. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giancotti FG and Ruoslahti E: Integrin
signaling. Science. 285:1028–1033. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hood JD and Cheresh DA: Role of integrins
in cell invasion and migration. Nat Rev Cancer. 2:91–100. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Howe A, Aplin AE, Alahari SK and Juliano
R: Integrin signaling and cell growth control. Curr Opin Cell Biol.
10:220–231. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo W, Pylayeva Y, Pepe A, Yoshioka T,
Muller WJ, Inghirami G and Giancottin FG: Beta 4 integrin amplifies
ErbB2 signaling to promote mammary tumorigenesis. Cell.
126:489–502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mariotti A, Kedeshian PA, Dans M, et al:
EGF-R signaling through Fyn kinase disrupts the function of
integrin alpha6beta4 at hemidesmosomes: Role in epithelial cell
migration and carcinoma invasion. J Cell Biol. 155:447–458. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nikolopoulos SN, Blaikie P, Yoshioka T,
Guo W and Giancotti FG: Integrin beta4 signaling promotes tumor
angiogenesis. Cancer Cell. 6:471–483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Trusolino L, Bertotti A and Comoglio PM: A
signaling adapter function for alpha6beta4 integrin in the control
of HGF-dependent invasive growth. Cell. 107:643–654. 2001.
View Article : Google Scholar : PubMed/NCBI
|
